Literature DB >> 22626059

What are the important subsets of gastroparesis?

M Camilleri1, M Grover, G Farrugia.   

Abstract

Gastroparesis is often divided into subsets based on etiology and pathophysiology; however, the utility of these subsets in the diagnosis and treatment of gastro-paresis is not well defined. The objectives are to consider the subsets of gastroparesis from the perspectives of etiology and pathogenesis, pathophysiology, histopathology, and clinical associations, with particular focus on similarities and differences between diabetic and idiopathic gastroparesis and consideration of the potential subset of painful gastroparesis. We conclude that idiopathic and diabetic gastroparesis has similar initial presentations and manifestations, except that idiopathic gastroparesis tends to be associated more frequently with pain. Myopathic disorders are uncommon. Extrinsic denervation was considered the most common etiology; however, with the decline in surgery for peptic ulceration and in-depth study of full-thickness gastric biopsies, the most common intrinsic defects are being recognized in the interstitial cells of Cajal (ICC-opathy) and with immune infiltration and neuronal changes (intrinsic neuropathic gastroparesis). Histomorphological differences at the microscopic level between diabetic and idiopathic gastroparesis are still of unclear significance. Two gastroparesis subsets worthy of special mention, because they are potentially reversible with identification of the cause, are postviral gastroparesis, which has a generally good prognosis, and iatrogenic gastroparesis, especially in patients with non-surgical gastroparesis, such as diabetics exposed to incretins such as pramlintide and exenatide.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22626059      PMCID: PMC3785986          DOI: 10.1111/j.1365-2982.2012.01942.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  51 in total

1.  Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients.

Authors:  A Fich; M Neri; M Camilleri; K A Kelly; S F Phillips
Journal:  J Clin Gastroenterol       Date:  1990-10       Impact factor: 3.062

2.  Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.

Authors:  M P Greydanus; M Camilleri
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

Review 3.  Study of human gastroduodenojejunal motility. Applied physiology in clinical practice.

Authors:  M Camilleri
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

4.  Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history.

Authors:  J J Oh; C H Kim
Journal:  Mayo Clin Proc       Date:  1990-05       Impact factor: 7.616

5.  Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies.

Authors:  M P Greydanus; M Camilleri; L J Colemont; S F Phillips; M L Brown; G M Thomforde
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

6.  Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis.

Authors:  M Horowitz; G J Maddern; A Maddox; J Wishart; B E Chatterton; D J Shearman
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

7.  Abnormal intestinal motility in diabetics with the gastroparesis syndrome.

Authors:  M Camilleri; J R Malagelada
Journal:  Eur J Clin Invest       Date:  1984-12       Impact factor: 4.686

Review 8.  Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis.

Authors:  M Vassallo; M Camilleri; B L Caron; P A Low
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

9.  Proximal gastric vagotomy, truncal vagotomy with drainage, and truncal vagotomy with antrectomy for chronic duodenal ulcer. A prospective, randomized controlled trial.

Authors:  J Koo; S K Lam; P Chan; N W Lee; P Lam; J Wong; G B Ong
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

10.  Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb.

Authors:  J R Mathias; A Fernandez; C A Sninsky; M H Clench; R H Davis
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  16 in total

1.  Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy: is gastroparesis a factor?

Authors:  Anna Tavakkoli; Bisma A Sayed; Nicholas J Talley; Baharak Moshiree
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 2.  Pyloric Therapies for Gastroparesis.

Authors:  Nitin K Ahuja; John O Clarke
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

3.  Tumor necrosis factor alpha derived from classically activated "M1" macrophages reduces interstitial cell of Cajal numbers.

Authors:  S T Eisenman; S J Gibbons; P-J Verhulst; G Cipriani; D Saur; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2016-10-25       Impact factor: 3.598

Review 4.  Interstitial cells of Cajal: update on basic and clinical science.

Authors:  Jan D Huizinga; Ji-Hong Chen
Journal:  Curr Gastroenterol Rep       Date:  2014-01

5.  Pathological Findings of the Antral and Pyloric Smooth Muscle in Patients with Gastroparesis-Like Syndrome Compared to Gastroparesis: Similarities and Differences.

Authors:  Mohammad Bashashati; Sharareh Moraveji; Alireza Torabi; Irene Sarosiek; Brian R Davis; Jesus Diaz; Richard W McCallum
Journal:  Dig Dis Sci       Date:  2017-06-02       Impact factor: 3.199

6.  Computational modeling of drug dissolution in the human stomach: Effects of posture and gastroparesis on drug bioavailability.

Authors:  J H Lee; S Kuhar; J-H Seo; P J Pasricha; R Mittal
Journal:  Phys Fluids (1994)       Date:  2022-08-09       Impact factor: 4.980

Review 7.  Macrophages in diabetic gastroparesis--the missing link?

Authors:  L Neshatian; S J Gibbons; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2014-08-28       Impact factor: 3.598

Review 8.  Novel Diet, Drugs, and Gastric Interventions for Gastroparesis.

Authors:  Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2016-01-04       Impact factor: 11.382

9.  Interleukin 10 Restores Gastric Emptying, Electrical Activity, and Interstitial Cells of Cajal Networks in Diabetic Mice.

Authors:  Kyoung Moo Choi; Simon J Gibbons; Lei Sha; Arthur Beyder; Pieter-Jan Verhulst; Gianluca Cipriani; Jessica E Phillips; Anthony J Bauer; Tamas Ordog; Jon J Camp; Xin Ge; Adil E Bharucha; David R Linden; Joseph H Szurszewski; Purna C Kashyap; Gianrico Farrugia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-04-23

10.  Diabetic Csf1op/op mice lacking macrophages are protected against the development of delayed gastric emptying.

Authors:  Gianluca Cipriani; Simon J Gibbons; Pieter-Jan Verhulst; Kyoung Moo Choi; Seth T Eisenman; Stephanie S Hein; Tamas Ordog; David R Linden; Joseph H Szurszewski; Gianrico Farrugia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.